Split History
ETFs Holding CTSO »    CTSO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cytosorbents is engaged in the treatment of life-threatening conditions in the intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology. Co. has several products commercialized and in development based on this technology platform. CytoSorb, Co.'s primary product, is approved in the European Union as an extracorporeal cytokine absorber, designed to reduce the cytokine storm that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. According to our CTSO split history records, Cytosorbents has had 2 splits.
CTSO split history picture
Cytosorbents (CTSO) has 2 splits in our CTSO split history database. The first split for CTSO took place on October 02, 2007. This was a 1 for 100 reverse split, meaning for each 100 shares of CTSO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 10 share position following the split. CTSO's second split took place on December 05, 2014. This was a 1 for 25 reverse split, meaning for each 25 shares of CTSO owned pre-split, the shareholder now owned 1 share. For example, a 10 share position pre-split, became a 0.4 share position following the split.

When a company such as Cytosorbents conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the CTSO split history from start to finish, an original position size of 1000 shares would have turned into 0.4 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cytosorbents shares, starting with a $10,000 purchase of CTSO, presented on a split-history-adjusted basis factoring in the complete CTSO split history. CTSO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/10/2012
End date: 12/06/2022
Start price/share: $3.50
End price/share: $1.28
Dividends collected/share: $0.00
Total return: -63.43%
Average Annual Total Return: -9.57%
Starting investment: $10,000.00
Ending investment: $3,659.02
Years: 9.99
Date Ratio
10/02/20071 for 100
12/05/20141 for 25
CTSO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CUR Split History
CVM Split History
CWBR Split History
CXM Split History
CYCC Split History
CYH Split History
CYTK Split History
CYTR Split History
CYTX Split History
DARA Split History

Also explore: CTSO shares outstanding history

Email EnvelopeFree CTSO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Checkpoint Therapeutics, Inc. (CKPT)
UpHealth, Inc. (UPH)
MediWound Ltd. (MDWD)
Eloxx Pharmaceuticals, Inc. (ELOX)
Baudax Bio, Inc. (BXRX)
Petros Pharmaceuticals, Inc. (PTPI)
Tuesday Morning Corporation (TUEM)
DURECT Corporation (DRRX)
CNS Pharmaceuticals, Inc. (CNSP)
Astrotech Corporation (ASTC)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CTSO Insider Buying

CTSO Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.